Four questions to predict cognitive decline in de novo Parkinson’s disease
Abstract Early identification of cognitive decline (CD) in de novo Parkinson’s disease (PD) is crucial for choosing appropriate therapies and recruiting for clinical trials. However, existing prognostic models lack flexibility, scalability and require costly instrumentation. This study explores the...
Saved in:
| Main Authors: | Jan Hlavnička, Josef Mana, Ondrej Bezdicek, Martin Čihák, Filip Havlík, Dominik Škrabal, Tereza Bartošová, Karel Šonka, Evžen Růžička, Petr Dušek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00958-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal analysis of pupillometry according to type of pharmacotherapy in Parkinson’s disease patients
by: Olga Bartošová, et al.
Published: (2025-08-01) -
The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI.
by: Robert Jech, et al.
Published: (2012-01-01) -
Automatic analysis of eyelid movement in de-novo Parkinson’s disease
by: Louis Kälble, et al.
Published: (2025-06-01) -
Glymphatic dysfunction evidenced by DTI-ALPS is related to obstructive sleep apnea intensity in newly diagnosed Parkinson’s disease
by: Jiri Nepozitek, et al.
Published: (2025-06-01) -
Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease.
by: Tomáš Sieger, et al.
Published: (2013-01-01)